423 related articles for article (PubMed ID: 17960478)
1. Innovative approaches for the treatment of depression: targeting the HPA axis.
Thomson F; Craighead M
Neurochem Res; 2008 Apr; 33(4):691-707. PubMed ID: 17960478
[TBL] [Abstract][Full Text] [Related]
2. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.
Scott LV; Dinan TG
Life Sci; 1998; 62(22):1985-98. PubMed ID: 9627097
[TBL] [Abstract][Full Text] [Related]
3. Early-life stress and HPA axis trigger recurrent adulthood depression.
Juruena MF
Epilepsy Behav; 2014 Sep; 38():148-59. PubMed ID: 24269030
[TBL] [Abstract][Full Text] [Related]
4. Hypothalamo-pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration: sex differences between major depressives and matched control subjects.
Rubin RT; O'Toole SM; Rhodes ME; Sekula LK; Czambel RK
Psychiatry Res; 1999 Dec; 89(1):1-20. PubMed ID: 10643873
[TBL] [Abstract][Full Text] [Related]
5. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ
J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
[TBL] [Abstract][Full Text] [Related]
6. Vasopressin V1B Receptor Antagonists as Potential Antidepressants.
Chaki S
Int J Neuropsychopharmacol; 2021 Jul; 24(6):450-463. PubMed ID: 33733667
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological strategies against glucocorticoid-mediated brain damage during chronic disorders.
Martocchia A; Curto M; Toussan L; Stefanelli M; Falaschi P
Recent Pat CNS Drug Discov; 2011 Sep; 6(3):196-204. PubMed ID: 21834781
[TBL] [Abstract][Full Text] [Related]
8. The stress system in the human brain in depression and neurodegeneration.
Swaab DF; Bao AM; Lucassen PJ
Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
[TBL] [Abstract][Full Text] [Related]
9. Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity.
Vicennati V; Ceroni L; Gagliardi L; Pagotto U; Gambineri A; Genghini S; Pasquali R
J Endocrinol Invest; 2004 Jun; 27(6):541-7. PubMed ID: 15717651
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
Inder WJ; Ellis MJ; Evans MJ; Donald RA
Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
[TBL] [Abstract][Full Text] [Related]
11. Chronic variable stress alters hypothalamic-pituitary-adrenal axis function in the female mouse.
Borrow AP; Heck AL; Miller AM; Sheng JA; Stover SA; Daniels RM; Bales NJ; Fleury TK; Handa RJ
Physiol Behav; 2019 Oct; 209():112613. PubMed ID: 31299374
[TBL] [Abstract][Full Text] [Related]
12. Post-dexamethasone arginine vasopressin levels in patients with severe mood disorders.
Watson S; Gallagher P; Ferrier IN; Young AH
J Psychiatr Res; 2006 Jun; 40(4):353-9. PubMed ID: 16165159
[TBL] [Abstract][Full Text] [Related]
13. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.
Nikisch G
Neuro Endocrinol Lett; 2009 Mar; 30(1):11-6. PubMed ID: 19300389
[TBL] [Abstract][Full Text] [Related]
14. Regulatory mechanism of hypothalamo-pituitary-adrenal (HPA) axis and neuronal changes after adrenalectomy in type 2 diabetes.
Yi SS; Hwang IK; Shin JH; Choi JH; Lee CH; Kim IY; Kim YN; Won MH; Park IS; Seong JK; Yoon YS
J Chem Neuroanat; 2010 Oct; 40(2):130-9. PubMed ID: 20472052
[TBL] [Abstract][Full Text] [Related]
15. Cortisol response patterns in depressed women and their healthy daughters at risk: Comparison with healthy women and their daughters.
Gonul AS; Cetinkalp S; Tunay S; Polat I; Simsek F; Aksoy B; Kizilates G; Erdogan Y; Coburn KL
J Psychiatr Res; 2017 Feb; 85():66-74. PubMed ID: 27837659
[TBL] [Abstract][Full Text] [Related]
16. Long-lasting deficient dexamethasone suppression of hypothalamic-pituitary-adrenocortical activation following peripheral CRF challenge in socially defeated rats.
Buwalda B; de Boer SF; Schmidt ED; Felszeghy K; Nyakas C; Sgoifo A; Van der Vegt BJ; Tilders FJ; Bohus B; Koolhaas JM
J Neuroendocrinol; 1999 Jul; 11(7):513-20. PubMed ID: 10444308
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic-pituitary-adrenal axis and depression symptom effects of an arginine vasopressin type 1B receptor antagonist in a one-week randomized Phase 1b trial.
Katz DA; Locke C; Greco N; Liu W; Tracy KA
Brain Behav; 2017 Mar; 7(3):e00628. PubMed ID: 28293470
[TBL] [Abstract][Full Text] [Related]
18. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
de Kloet C; Vermetten E; Lentjes E; Geuze E; van Pelt J; Manuel R; Heijnen C; Westenberg H
Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
[TBL] [Abstract][Full Text] [Related]
19. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
Connan F; Lightman SL; Landau S; Wheeler M; Treasure J; Campbell IC
J Psychiatr Res; 2007; 41(1-2):131-43. PubMed ID: 16455105
[TBL] [Abstract][Full Text] [Related]
20. Early environmental regulation of forebrain glucocorticoid receptor gene expression: implications for adrenocortical responses to stress.
Meaney MJ; Diorio J; Francis D; Widdowson J; LaPlante P; Caldji C; Sharma S; Seckl JR; Plotsky PM
Dev Neurosci; 1996; 18(1-2):49-72. PubMed ID: 8840086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
